PERK-dependent eIF2α phosphorylation has been found to be indispensable for the survival of a subpopulation of hypoxic tumor cells highly resistant to chemotherapy attributable to GSH synthesis induction and ROS defense [201]. Here, EIF2A is linked to neoplasm.